OBSERVATIONS

 The primary efficacy endpoint was the proportion of patients achieving “Responder rate” at the end of the treatment. The secondary efficacy endpoint was the proportion of patients achieving “complete cure”.

 

 

Participant flow: overall study

 

Started.....................................................128

Completed..............................................122

Diabetics.................................................. 17

Not completed.........................................  3

Lost to follow up......................................  4

Participant NON-compliance.................  2

 

 

The following graph shows the average healing rate of the destroyed/infected nails in the course of 6 months whilst undergoing treatment with Myco Onyx:

The efficacy of Myco Onyx in the treatment of onychomycosis is illustrated by the response of patients with toenail and/or fingernail infections who participated in the clinical study.

 

The following pictures present several cases of onychomycosis and the progress of monotherapy by Myco Onyx nail solution. Some of the cases presented are ongoing.

 

Certain observations during application with Myco Onyx:

 

  • Side effects and drug interactions were not observed during the treatments with Myco Onyx nail solution.

 

  • Treatment via the topical administration of the Myco Onyx nail solution is effective even in the most difficult cases since the recovered nail bed cells, by the mechanism of mitosis, replicate and recover their defensive mechanisms. Keratinocytes begin to produce more keratin and the healing process improves.

 

  • The said treatment is even effective in diabetic patients were diabetic angiopathy and neuropathy in combination with onychomycosis can cause serious problems.

 

  • Sensitivity of the destroyed nail starts to recover during the 1st month of the treatment.

 

  • The first positive results appear in less than a month.

 

  • Grey Facebook Icon
  • Grey Instagram Icon

Private Policy

Terms of Use

Copyright © 2016 | MGRP Co. LTD |